IP Library › Granted Patent US 10,577,592
Granted Patent B2
US 10,577,592 · App. 16/177,562 · Granted Mar 3, 2020

Compositions and methods for protein glycosylation

Inventors: Jurgen Haas (Basel, CH); Julian Ihssen (Dübendorf, CH); Michael Thomas Kowarik (Schlieren, CH); Torsten Franz Schwede (Basel, CH); Linda Christiane Thöny-Meyer (Dübendorf, CH)
Assignee: GlaxoSmithKline Biologicals SA
C12N9/1081C12P21/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,577,592
App. No.
16/177,562
Granted
Mar 3, 2020
Kind
B2
Abstract

Described herein are oligosaccharyl transferases for use in N-glycosylating proteins of interest in vitro and in host cells. Methods for using such oligosaccharyl transferases, nucleic acids encoding such oligosaccharyl transferases, and host cells comprising such oligosaccharyl transferases are also provided herein. Glycoconjugates generated by using such oligosaccharyl transferases are also provided herein.

Claims (19)

1. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

2. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

3. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 311 of the polypeptide of SEQ ID NO: 1.

4. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 77 of the polypeptide of SEQ ID NO: 1.

5. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase further comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, 290, 291, 292, 293, and 294.

6. The N-oligosaccharyl transferase of claim 5 , wherein said N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of positions 287, 288, 289, and 294.

7. A host cell comprising the N-oligosaccharyl transferase of claim 1 or claim 4 .

8. A method of producing a bioconjugate comprising culturing the host cell of claim 7 in a cell culture medium and purifying the bioconjugate from the host cell culture.

9. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:1, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

10. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 2, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

11. The N-oligosaccharyl transferase of claim 10 , wherein said N-oligosaccharyl transferase comprises two or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488 and 489.

12. The N-oligosaccharyl transferase of claim 10 , wherein said N-oligosaccharyl transferase comprises a substitution at a position corresponding to position 314 of the polypeptide of SEQ ID NO: 2.

13. A nucleic acid encoding an N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 2 selected from the group consisting of 79, 82, 314, 488, and 489.

14. A host cell comprising the N-oligosaccharyl transferase of claim 10 or claim 12 .

15. A method of producing a bioconjugate comprising culturing the host cell of claim 14 in a cell culture medium and purifying the bioconjugate from the host cell culture.

16. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 1 and a fragment comprising at least 100 consecutive amino acids of SEQ ID NO: 1, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 77, 80, 196, 311, 462, 482, 483, and 477.

17. An N-oligosaccharyl transferase comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 2 and a fragment comprising at least 100 consecutive amino acids of SEQ ID NO: 2, wherein the N-oligosaccharyl transferase comprises one or more substitutions at positions corresponding to positions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of 79, 82, 314, 488, and 489.

18. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises substitutions at positions corresponding to positions 77 and 311 in the polypeptide of SEQ ID NO: 1.

19. The N-oligosaccharyl transferase of claim 1 , wherein said N-oligosaccharyl transferase comprises substitutions at positions corresponding to positions 80 and 311 in the polypeptide of SEQ ID NO: 1.

Continuity (4)
Continuation 15540690
Provisional Application 62097975 · Dec 30, 2014
Provisional Application 62098071 · Dec 30, 2014
Related Publication 20190078064A1 · Mar 14, 2019
Cited By (4)
US 12,214,029 US 12,233,118 US 12,233,121 US 12,274,742